Sachin Kumar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sachin Kumar has a total of 164 co-authors. Here are the top co-authors by number of shared publications:
- Shriyansh Srivastava
Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida 203201, India
16 shared publications - Aroop Mohanty
AIIMS Gorakhpur, India
8 shared publications - Rachana Mehta
Clinical Microbiology, RDC, Manav Rachna International Institute of Research and Studies, Faridabad, Haryana, 121004, India
8 shared publications - Ranjit Sah
Boston Medical Center Health System, Boston, USA
8 shared publications Laxmi Yadav
Department of Pharmacology, Delhi Institute of Pharmaceutical Sciences and Research, Delhi Pharmaceutical Sciences and Research University, New Delhi, India
6 shared publications- Vasso Apostolopoulos
School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC 3000, Australia
6 shared publications
Latest Publications
- Open Access
- 1 September 2026
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 20 (3) , 2076
Gut Microbiome Signatures in Hepatocellular Carcinoma: Implications for Diagnosis, Prognosis and Therapy
Hepatocellular carcinoma (HCC) increases cancer-related mortality globally. The disease is diagnosed through imaging and serum biomarkers that lack sensitivity in the early stages of the disease. In this narrative review, a comprehensive literature search was conducted using databases including PubMed, Scopus, and Web of Science to identify relevant studies published during the last five years. The search focused on studies evaluating the relationship between gut microbiota and HCC, including microbial dysbiosis, microbial signatures, metabolites, diagnostic/prognostic potential, and microbiome-based therapeutic approaches. Relevant articles were selected based on predefined inclusion and exclusion criteria, and the findings were qualitatively synthesized to provide an updated overview of the role of the gut microbiome in HCC. The microbial signatures link the gut with HCC by focusing on key taxa like Bacteroidetes, Firmicutes, and Proteobacteria. In addition, further examination focuses on the functional impact of the microbiome, including microbial metabolites that are bile acids, short-chain fatty acids, and lipopolysaccharides that further control inflammation and immune responses, leading to carcinogenesis. Moreover, the review explored microbiome-modulating therapies like prebiotics, probiotics, and fecal microbiota transplantation (FMT) as possible adjuncts to conventional treatments like immunotherapy and chemotherapy. Ultimately, the study highlighted issues in the standardization of microbiome-based interventions and the requirement of a personalized approach for microbiome therapy in the treatment of HCC. The review also highlighted the potential of microbiome-targeted therapies and diagnostics to improve HCC outcomes and offered a unique direction for future research and clinical practice.
- 1 September 2026
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 20 (3) , 2076
Open AccessGut Microbiome Signatures in Hepatocellular Carcinoma: Implications for Diagnosis, Prognosis and Therapy
Hepatocellular carcinoma (HCC) increases cancer-related mortality globally. The disease is diagnosed through imaging and serum biomarkers that lack sensitivity in the early stages of the disease. In this narrative review, a comprehensive literature search was conducted using databases including PubMed, Scopus, and Web of Science to identify relevant studies published during the last five years. The search focused on studies evaluating the relationship between gut microbiota and HCC, including microbial dysbiosis, microbial signatures, metabolites, diagnostic/prognostic potential, and microbiome-based therapeutic approaches. Relevant articles were selected based on predefined inclusion and exclusion criteria, and the findings were qualitatively synthesized to provide an updated overview of the role of the gut microbiome in HCC. The microbial signatures link the gut with HCC by focusing on key taxa like Bacteroidetes, Firmicutes, and Proteobacteria. In addition, further examination focuses on the functional impact of the microbiome, including microbial metabolites that are bile acids, short-chain fatty acids, and lipopolysaccharides that further control inflammation and immune responses, leading to carcinogenesis. Moreover, the review explored microbiome-modulating therapies like prebiotics, probiotics, and fecal microbiota transplantation (FMT) as possible adjuncts to conventional treatments like immunotherapy and chemotherapy. Ultimately, the study highlighted issues in the standardization of microbiome-based interventions and the requirement of a personalized approach for microbiome therapy in the treatment of HCC. The review also highlighted the potential of microbiome-targeted therapies and diagnostics to improve HCC outcomes and offered a unique direction for future research and clinical practice.
- Open Access
- 1 April 2026
- Published by Wolters Kluwer Health in Asian Journal of Pharmaceutical Research and Health Care
- Vol. 18 (2) , 213-220
Electrochemical Characterization and Standardization of Nanoparticle-modified Screen-printed Carbon Electrodes for Future Biosensor Applications
A BSTRACT: Background: Electrochemical biosensors can analyze biomarkers quickly and accurately. However, surface modification techniques and surface modification materials can affect their working. Aims and Objectives: In this study, three different methods of screen-printed carbon electrode (SPCE) modification were tested and compared. Materials and Methods: Zinc oxide nanoparticles (ZnONPs), gold nanoparticles (AuNPs), and electrodeposited gold were used for SPCE modification. ZnONPs and AuNPs were synthesized and characterized using UV-Vis spectroscopy, FTIR, XRD, DLS, and SEM. ZnONPs and AuNPs were drop-cast on the working electrode of SPCE, while hydrochloroauric acid (HAuCl₄) was used to deposit gold in nanoform via chronoamperometry. All the modified SPCEs were subjected to cyclic voltammetry for assessment and comparison with the bare (unmodified) SPCE. One-way ANOVA with Tukey's post-hoc test was used for statistical analysis. Results: It was found that ZnONP modification performed best at a concentration of 0.75 mg/mL, producing a peak current of 0.29 mA. The undiluted AuNP suspensions did better, reaching 0.45 mA. Among the methods examined, electrodeposited gold, using 20 µM HAuCl₄ solution, delivered the highest peak current of 0.79 mA and the largest electroactive surface area of 0.53 cm². Conclusion: The standardized conditions established herein are expected to serve as a reproducible SPCE platform for future biosensor development. This is particularly relevant for point-of-care detection of clinically relevant biomarkers.
- 1 April 2026
- Published by Wolters Kluwer Health in Asian Journal of Pharmaceutical Research and Health Care
- Vol. 18 (2) , 213-220
Open AccessElectrochemical Characterization and Standardization of Nanoparticle-modified Screen-printed Carbon Electrodes for Future Biosensor Applications
A BSTRACT: Background: Electrochemical biosensors can analyze biomarkers quickly and accurately. However, surface modification techniques and surface modification materials can affect their working. Aims and Objectives: In this study, three different methods of screen-printed carbon electrode (SPCE) modification were tested and compared. Materials and Methods: Zinc oxide nanoparticles (ZnONPs), gold nanoparticles (AuNPs), and electrodeposited gold were used for SPCE modification. ZnONPs and AuNPs were synthesized and characterized using UV-Vis spectroscopy, FTIR, XRD, DLS, and SEM. ZnONPs and AuNPs were drop-cast on the working electrode of SPCE, while hydrochloroauric acid (HAuCl₄) was used to deposit gold in nanoform via chronoamperometry. All the modified SPCEs were subjected to cyclic voltammetry for assessment and comparison with the bare (unmodified) SPCE. One-way ANOVA with Tukey's post-hoc test was used for statistical analysis. Results: It was found that ZnONP modification performed best at a concentration of 0.75 mg/mL, producing a peak current of 0.29 mA. The undiluted AuNP suspensions did better, reaching 0.45 mA. Among the methods examined, electrodeposited gold, using 20 µM HAuCl₄ solution, delivered the highest peak current of 0.79 mA and the largest electroactive surface area of 0.53 cm². Conclusion: The standardized conditions established herein are expected to serve as a reproducible SPCE platform for future biosensor development. This is particularly relevant for point-of-care detection of clinically relevant biomarkers.
- Open Access
- 1 January 2026
- Published by Wolters Kluwer Health in Asian Journal of Pharmaceutical Research and Health Care
- Vol. 18 (1) , 53-61
Evaluation of Sedative and Anxiolytic Properties of Violet Oil: A Gas Chromatography-mass Spectrometry and Network Pharmacology-based Study in Swiss Albino Mice
A BSTRACT: Background: Anxiety and insomnia are prevalent global health issues with limited effective treatments. Viola odorata L. (sweet violet) is traditionally known for its calming effects, although scientific validation remains sparse. Objective: This study investigated the sedative and anxiolytic potential of violet oil derived from V. odorata using phytochemical profiling, network pharmacology, and animal behavioral models. Materials and Methods: Bioactive constituents of violet oil were identified using gas chromatography-mass spectrometry (GC-MS). Network pharmacology analysis predicted molecular targets and pathways. Swiss albino mice were orally administered violet oil (2, 4, or 8 mg/kg), with diazepam (1 mg/kg, i.p.) and vehicle serving as controls. Behavioral assays – rota-rod, elevated plus maze, actophotometer, light-dark box, and hole board – evaluated sedative and anxiolytic effects. Results: GC-MS identified 36 compounds, notably humulene (45.3%), alpha-ionone (15.88%), caryophyllene (9.88%), and alpha-isomethyl ionone (9.71%). Network pharmacology revealed 23 potential targets and 17 pathways, including those related to circadian rhythm and thyroid hormone signaling. Violet oil at 8 mg/kg significantly increased falls in the rota-rod test ( P < 0.05), indicating muscle relaxation. In the elevated plus maze, doses of 2 and 8 mg/kg increased time spent in open arms ( P < 0.01 and P < 0.05), suggesting anxiolytic activity. All doses reduced locomotor activity ( P < 0.05 to P < 0.001) and increased time in the illuminated area of the light-dark box ( P < 0.05 to P < 0.01), comparable to diazepam. Conclusion: Violet oil from V. odorata exhibits notable sedative and anxiolytic effects, likely mediated via multiple pathways involving terpenes and ionones. These results support its traditional use for anxiety and sleep disorders and suggest its potential as a natural therapeutic agent.
- 1 January 2026
- Published by Wolters Kluwer Health in Asian Journal of Pharmaceutical Research and Health Care
- Vol. 18 (1) , 53-61
Open AccessEvaluation of Sedative and Anxiolytic Properties of Violet Oil: A Gas Chromatography-mass Spectrometry and Network Pharmacology-based Study in Swiss Albino Mice
A BSTRACT: Background: Anxiety and insomnia are prevalent global health issues with limited effective treatments. Viola odorata L. (sweet violet) is traditionally known for its calming effects, although scientific validation remains sparse. Objective: This study investigated the sedative and anxiolytic potential of violet oil derived from V. odorata using phytochemical profiling, network pharmacology, and animal behavioral models. Materials and Methods: Bioactive constituents of violet oil were identified using gas chromatography-mass spectrometry (GC-MS). Network pharmacology analysis predicted molecular targets and pathways. Swiss albino mice were orally administered violet oil (2, 4, or 8 mg/kg), with diazepam (1 mg/kg, i.p.) and vehicle serving as controls. Behavioral assays – rota-rod, elevated plus maze, actophotometer, light-dark box, and hole board – evaluated sedative and anxiolytic effects. Results: GC-MS identified 36 compounds, notably humulene (45.3%), alpha-ionone (15.88%), caryophyllene (9.88%), and alpha-isomethyl ionone (9.71%). Network pharmacology revealed 23 potential targets and 17 pathways, including those related to circadian rhythm and thyroid hormone signaling. Violet oil at 8 mg/kg significantly increased falls in the rota-rod test ( P < 0.05), indicating muscle relaxation. In the elevated plus maze, doses of 2 and 8 mg/kg increased time spent in open arms ( P < 0.01 and P < 0.05), suggesting anxiolytic activity. All doses reduced locomotor activity ( P < 0.05 to P < 0.001) and increased time in the illuminated area of the light-dark box ( P < 0.05 to P < 0.01), comparable to diazepam. Conclusion: Violet oil from V. odorata exhibits notable sedative and anxiolytic effects, likely mediated via multiple pathways involving terpenes and ionones. These results support its traditional use for anxiety and sleep disorders and suggest its potential as a natural therapeutic agent.
- 24 November 2025
- Published by Springer Nature in Medical Oncology
- Vol. 43 (1) , 18
Microbial oncogenesis: the impact of Fusobacterium nucleatum on oral cancer pathways
The potential role of Fusobacterium nucleatum, bacterium that is a major and regular inhabitant of the oral cavity, in the progression of oral cancer through various mechanisms, including adhesion, immune perturbation, and its potential associations with different signalling pathways. Scientists have already demonstrated that infection with bacteria can cause them to adhere to oral epithelial cells, leading to their invasion of host tissues, as shown through in vitro, preclinical, and clinical studies. Furthermore, Fusobacterium nucleatum alters the tumour microenvironment, inciting inflammation, and shifts in the immune system to enhance tumour growth. It also modifies important signaling pathways (e.g. Wnt/ β-catenin pathways), which are associated with cell proliferation and survival, characteristics of cancer progression. The study provides a clear demonstration of these processes and discusses implications for the bacteria in terms of medical diagnosis and therapies for patients. Studies involving Fusobacterium nucleatum offer an important window into potential therapeutic targeting of immune responses and pathways in the context of oral cancer. This research builds upon Fusobacterium nucleatum, identified as a therapeutic target, and provides several case examples of how precision medicine may be applied to oral cancer treatment. Graphical abstract
- 24 November 2025
- Published by Springer Nature in Medical Oncology
- Vol. 43 (1) , 18
Microbial oncogenesis: the impact of Fusobacterium nucleatum on oral cancer pathways
The potential role of Fusobacterium nucleatum, bacterium that is a major and regular inhabitant of the oral cavity, in the progression of oral cancer through various mechanisms, including adhesion, immune perturbation, and its potential associations with different signalling pathways. Scientists have already demonstrated that infection with bacteria can cause them to adhere to oral epithelial cells, leading to their invasion of host tissues, as shown through in vitro, preclinical, and clinical studies. Furthermore, Fusobacterium nucleatum alters the tumour microenvironment, inciting inflammation, and shifts in the immune system to enhance tumour growth. It also modifies important signaling pathways (e.g. Wnt/ β-catenin pathways), which are associated with cell proliferation and survival, characteristics of cancer progression. The study provides a clear demonstration of these processes and discusses implications for the bacteria in terms of medical diagnosis and therapies for patients. Studies involving Fusobacterium nucleatum offer an important window into potential therapeutic targeting of immune responses and pathways in the context of oral cancer. This research builds upon Fusobacterium nucleatum, identified as a therapeutic target, and provides several case examples of how precision medicine may be applied to oral cancer treatment. Graphical abstract
- Open Access
- 10 September 2025
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 191, 118531
Targeting protein misfolding in Alzheimer’s disease: The emerging role of molecular chaperones
- 10 September 2025
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 191, 118531
Open AccessTargeting protein misfolding in Alzheimer’s disease: The emerging role of molecular chaperones
- 20 August 2025
- Published by Wiley in Biotechnology and Applied Biochemistry
- Vol. 73 (2) , 845-861
Signal Amplification to Improve Electrochemical Biosensing for Infectious Diseases
Infectious disease detection and monitoring are critical for public health management. Electrochemical biosensors have emerged as promising tools for rapid and sensitive detection of infectious diseases. This review explores signal amplification approaches to improve the sensitivity and limit of detection of electrochemical biosensors for infectious diseases. Enzymatic signal amplification methods, utilizing enzymes such as endonuclease, nucleotidyl transferase, DT‐diaphorase, and alkaline phosphatase, are discussed along with examples of their application in detecting tuberculosis, HIV, and COVID‐19. Nanoparticle‐based amplification approaches, including gold nanoparticles, quantum dots, and magnetic nanoparticles, are explored, highlighting their utility in detecting hepatitis B, Zika virus , and Ebola virus . Additionally, label‐free amplification techniques such as electrochemical impedance spectroscopy and surface plasmon resonance are examined, with examples demonstrating their efficacy in detecting dengue virus and influenza virus. Hybrid signal amplification methods combining enzymatic, nanoparticle‐based, and label‐free approaches are also discussed, showcasing their potential in detecting malaria and bacterial infections. Challenges such as the need for point‐of‐care testing and overcoming interferences are addressed, along with future research directions, including multiplexed assays and integration with smartphones for data analysis. This review provides insights into the diverse signal amplification strategies for electrochemical biosensors and their impact on infectious disease diagnosis and control.
- 20 August 2025
- Published by Wiley in Biotechnology and Applied Biochemistry
- Vol. 73 (2) , 845-861
Signal Amplification to Improve Electrochemical Biosensing for Infectious Diseases
Infectious disease detection and monitoring are critical for public health management. Electrochemical biosensors have emerged as promising tools for rapid and sensitive detection of infectious diseases. This review explores signal amplification approaches to improve the sensitivity and limit of detection of electrochemical biosensors for infectious diseases. Enzymatic signal amplification methods, utilizing enzymes such as endonuclease, nucleotidyl transferase, DT‐diaphorase, and alkaline phosphatase, are discussed along with examples of their application in detecting tuberculosis, HIV, and COVID‐19. Nanoparticle‐based amplification approaches, including gold nanoparticles, quantum dots, and magnetic nanoparticles, are explored, highlighting their utility in detecting hepatitis B, Zika virus , and Ebola virus . Additionally, label‐free amplification techniques such as electrochemical impedance spectroscopy and surface plasmon resonance are examined, with examples demonstrating their efficacy in detecting dengue virus and influenza virus. Hybrid signal amplification methods combining enzymatic, nanoparticle‐based, and label‐free approaches are also discussed, showcasing their potential in detecting malaria and bacterial infections. Challenges such as the need for point‐of‐care testing and overcoming interferences are addressed, along with future research directions, including multiplexed assays and integration with smartphones for data analysis. This review provides insights into the diverse signal amplification strategies for electrochemical biosensors and their impact on infectious disease diagnosis and control.
- Open Access
- 15 July 2025
- Published by MDPI AG in Preprints.org
Targeting Mpox: From Pharmacological Mechanisms to Next-Generation Therapies
Mpox, a zoonotic Orthopoxvirus, is a growing global health concern with clinical symptoms like smallpox, including fever, lymphadenopathy, and distinctive rashes. The increasing number of cases emphasizes how urgently antivirals and vaccinations are needed. Antiviral options like tecovirimat, cidofovir, and brincidofovir target DNA polymerase and viral assembly but show varying efficacy. Vaccines such as JYNNEOS and ACAM2000 provide cross-protection, while advancements in mRNA vaccines and recombinant viral vectors offer future promise. Mpox replicates its genome via DNA-dependent RNA polymerase, using envelope proteins for cell entry and evading immune responses through interferon signalling disruption and NF-κB activation. Challenges remain in improving animal models, addressing drug resistance, and ensuring equitable vaccine access. Bioinformatics-driven vaccine design and computational drug repurposing offer rapid solutions for Mpox. PoxApp, a mobile app for symptom tracking and AI analysis, and MPXV-CNN, a model for detecting Mpox image lesions, will accelerate diagnosis and monitoring. Strong pharmacovigilance, innovative treatments, and global collaboration are key to combating Mpox and improving public health resilience.
- 15 July 2025
- Published by MDPI AG in Preprints.org
Open AccessTargeting Mpox: From Pharmacological Mechanisms to Next-Generation Therapies
Mpox, a zoonotic Orthopoxvirus, is a growing global health concern with clinical symptoms like smallpox, including fever, lymphadenopathy, and distinctive rashes. The increasing number of cases emphasizes how urgently antivirals and vaccinations are needed. Antiviral options like tecovirimat, cidofovir, and brincidofovir target DNA polymerase and viral assembly but show varying efficacy. Vaccines such as JYNNEOS and ACAM2000 provide cross-protection, while advancements in mRNA vaccines and recombinant viral vectors offer future promise. Mpox replicates its genome via DNA-dependent RNA polymerase, using envelope proteins for cell entry and evading immune responses through interferon signalling disruption and NF-κB activation. Challenges remain in improving animal models, addressing drug resistance, and ensuring equitable vaccine access. Bioinformatics-driven vaccine design and computational drug repurposing offer rapid solutions for Mpox. PoxApp, a mobile app for symptom tracking and AI analysis, and MPXV-CNN, a model for detecting Mpox image lesions, will accelerate diagnosis and monitoring. Strong pharmacovigilance, innovative treatments, and global collaboration are key to combating Mpox and improving public health resilience.
- 2 July 2025
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 20 (4) , 1-16
Development and Assessment of Electrospun Nanofibrous Wound Dressing Containing Curcumin and Wedelolactone
- 2 July 2025
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 20 (4) , 1-16
Development and Assessment of Electrospun Nanofibrous Wound Dressing Containing Curcumin and Wedelolactone
- Open Access
- 1 July 2025
- Published by Advanced Research Publications in Chettinad Health City Medical Journal
- Vol. 14 (02) , 78-86
Revolutionizing Pharmacovigilance: The Role of Artificial Intelligence in Enhancing Patient Safety
Background: Pharmacovigilance (PV) is responsible for monitoring drug safety, and Artificial Intelligence (AI) is a promising technology that has the potential to transform this field.Objective: This article will investigate the role of AI in PV and its potential benefits for patient safety and healthcare providers.Methods: A structured review of relevant literature was conducted to identify studies that demonstrate the applications of AI in PV. The identified studies were analysed to determine the specific roles of AI in PV and its potential benefits.Results: The practice of AI in PV allows for the analysis of large datasets, adverse event reporting, the detection of safety signals, the prioritisation of safety issues, data mining, and predictive modelling. The benefits of AI in PV include improved efficiency, increased accuracy, enhanced patient safety, faster analysis of safety issues related to drugs, and reduced healthcare costs.Conclusion: AI has enormous potential to improve PV by streamlining case processing and improving the identification of adverse events. However, there are also challenges that need to be addressed in implementing AI in PV. Overall, AI has significant promise for enhancing patient safety and reducing healthcare costs. How to cite this article:Kumar S, Agarwal P, Kumar S. Revolutionizing Pharmacovigilance: The Role of Artificial Intelligence in Enhancing Patient Safety. Chettinad Health City Med J. 2025;14(2):78-86. DOI: https://doi.org/10.24321/2278.2044.202527
- 1 July 2025
- Published by Advanced Research Publications in Chettinad Health City Medical Journal
- Vol. 14 (02) , 78-86
Open AccessRevolutionizing Pharmacovigilance: The Role of Artificial Intelligence in Enhancing Patient Safety
Background: Pharmacovigilance (PV) is responsible for monitoring drug safety, and Artificial Intelligence (AI) is a promising technology that has the potential to transform this field.Objective: This article will investigate the role of AI in PV and its potential benefits for patient safety and healthcare providers.Methods: A structured review of relevant literature was conducted to identify studies that demonstrate the applications of AI in PV. The identified studies were analysed to determine the specific roles of AI in PV and its potential benefits.Results: The practice of AI in PV allows for the analysis of large datasets, adverse event reporting, the detection of safety signals, the prioritisation of safety issues, data mining, and predictive modelling. The benefits of AI in PV include improved efficiency, increased accuracy, enhanced patient safety, faster analysis of safety issues related to drugs, and reduced healthcare costs.Conclusion: AI has enormous potential to improve PV by streamlining case processing and improving the identification of adverse events. However, there are also challenges that need to be addressed in implementing AI in PV. Overall, AI has significant promise for enhancing patient safety and reducing healthcare costs. How to cite this article:Kumar S, Agarwal P, Kumar S. Revolutionizing Pharmacovigilance: The Role of Artificial Intelligence in Enhancing Patient Safety. Chettinad Health City Med J. 2025;14(2):78-86. DOI: https://doi.org/10.24321/2278.2044.202527